[CADL] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
31-Dec-2019
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY-
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 0 125 125 125 125 -
PBT -37,939 -18,794 -36,124 -17,680 -8,240 46.44%
Tax 0 -15,928 53 4,494 -226 -
NP -37,939 -2,866 -36,177 -22,174 -8,014 47.46%
Tax Rate - - - - - -
Total Cost 37,939 2,991 36,302 22,299 8,139 46.89%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin 0.00 -2,292.80 -28,941.60 -17,739.20 -6,411.20 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -1.31 -0.10 -1.26 -0.76 -0.27 48.37%
EPS Diluted -1.31 -0.10 -1.26 -0.76 -0.27 48.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.